Lupin takes "more shots at the goal" with $880m US buy
This article was originally published in Scrip
Executive Summary
Lupin has snapped up the privately owned niche firm Gavis Pharmaceuticals LLC and Novel Laboratories for $880m, marking India's largest pharma buyout in the US in recent times.